Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Tesaro gains development rights to antiemetic rolapitant hydrochloride

Dec. 16, 2010

Orion identifies novel inhibitors of MT-SP1

Dec. 16, 2010

MGN-1601 enters phase I/II study in advanced renal cancer

Dec. 16, 2010

MLN-0905 has antitumor effects in murine model of diffuse large B-cell lymphoma

Dec. 16, 2010

Phase I data support safety of BIIB-021 plus trastuzumab in HER2-positive breast cancer

Dec. 16, 2010

ONO-013105 synergizes with rituximab in models of MCL and advances in phase I trial

Dec. 16, 2010

HG-829 reverses resistance to antineoplastic agents in vitro and in vivo

Dec. 16, 2010

Phase II trial of EGEN-001 in advanced ovarian cancer opens enrollment

Dec. 15, 2010

CCX-721 has antitumor effects in murine model of multiple myeloma

Dec. 15, 2010

Lilly suspends phase III trial of tasisulam in metastatic melanoma

Dec. 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...